Germline mutations in shelterin complex genes are associated with familial glioma

Journal of the National Cancer Institute

Volumn 107, Issue 1, 2015, Pages

  Bainbridge, Matthew N ^a,b   Armstrong, Georgina N ^c   Gramatges, M Monica ^c   Bertuch, Alison A ^c   Jhangiani, Shalini N ^a   Doddapaneni, Harsha ^a   Lewis, Lora ^a   Tombrello, Joseph ^a   Tsavachidis, Spyros ^c   Liu, Yanhong ^c   Jalali, Ali ^a   Plon, Sharon E ^c   Lau, Ching C ^c   Parsons, Donald W ^c   Claus, Elizabeth B ^d,e   Barnholtz Sloan, Jill ^f   Il'yasova, Dora ^g,h   Schildkraut, Joellen ^h   Ali Osman, Francis ^h   Sadetzki, Siegal ^j   Johansen, Christoffer ^k   Houlston, Richard S ^l   Jenkins, Robert B ^m   Lachance, Daniel ^m   Olson, Sara H ⁿ   Bernstein, Jonine L ⁿ   Merrell, Ryan T ^o   Wrensch, Margaret R ^p   Walsh, Kyle M ^p   Davis, Faith G ^q   Lai, Rose ^r   Shete, Sanjay ^i,s   Aldape, Kenneth ^s   Amos, Christopher I ^t   Thompson, Patricia A ^u   Muzny, Donna M ^a   Gibbs, Richard A ^a   Melin, Beatrice S ^v   Bondy, Melissa L ^c   more..

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Codified Genomics LLC ^*  (United States)

^c Dan L Duncan Cancer Center   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g GEORGIA STATE UNIVERSITY   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ Cancer and Radiation Epidemiology Unit Gertner Institute Chaim Sheba Medical Center   (United States)

^j TEL AVIV UNIVERSITY   (Israel)

^k INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^l INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^m MAYO CLINIC CANCER CENTER   (United States)

ⁿ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^o NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q UNIVERSITY OF ALBERTA   (Canada)

^r UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^s UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^t DARTMOUTH MEDICAL SCHOOL   (United States)

^u UNIVERSITY OF ARIZONA   (United States)

^v UMEÅ UNIVERSITY   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN POT1; PROTEIN TPP1; UNCLASSIFIED DRUG; POT1 PROTEIN, HUMAN; SHELTERIN, HUMAN; TELOMERE BINDING PROTEIN;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA BINDING; EXOME; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; GERMLINE MUTATION; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; SOMATIC MUTATION; TELOMERE HOMEOSTASIS; VERY ELDERLY; BRAIN TUMOR; GENETICS; PEDIGREE;

ADULT; AGED; BRAIN NEOPLASMS; EXOME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; GLIOMA; HUMANS; MALE; MIDDLE AGED; OLIGODENDROGLIOMA; PEDIGREE; TELOMERE-BINDING PROTEINS;

EID: 84930462553     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju384     Document Type: Article

References (19)

1. Sadetzki S, Bruchim R, Oberman B, et al. Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium. Eur J Cancer Oxf Engl 1990. 2013;49(6):1335-1345.
2. Ostrom Q, Bauchet L, Davis F, Fisher J, Langer C, Pekmezci M. The epidemiology of glioma in adults: a review. Neuro-Onc. 2014;16(7):896-913.
3. Xie H, Wu X, Wang S, et al. Long telomeres in peripheral blood leukocytes are associated with an increased risk of soft tissue sarcoma. Cancer. 2013;119(10):1885-1891.
4. Wang S, Chen Y, Qu F, et al. Association between leukocyte telomere length and glioma risk: a case-control study. Neuro-Oncol. 2014;16(4):505-512.
5. Walcott F, Rajaraman P, Gadalla SM, et al. Telomere length and risk of glioma. Cancer Epidemiol. 2013;37(6):935-938.
6. Melin BS, Nordfjäll K, Andersson U, Roos G. hTERT cancer risk genotypes are associated with telomere length. Genet Epidemiol. 2012;36(4):368-372.
7. Malmer B, Adatto P, Armstrong G, et al. GLIOGENE an International Consortium to Understand Familial Glioma. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2007;16(9):1730-1734.
8. Bainbridge MN, Wang M, Wu Y, et al. Targeted enrichment beyond the consensus coding DNA sequence exome reveals exons with higher variant densities. Genome Biol. 2011;12(7):R68.
9. Bainbridge MN, Hu H, Muzny DM, et al. De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndrome. Genome Med. 2013;5(2):11.
10. Forbes SA, Bindal N, Bamford S, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 2011;39(Database issue):D945-950.
11. Baumann P, Cech TR. Pot1, the putative telomere endbinding protein in fission yeast and humans. Science. 2001;292(5519):1171-1175.
12. Hockemeyer D, Sfeir AJ, Shay JW, Wright WE, de Lange T. POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end. EMBO J. 2005;24(14):2667-2678.
13. Nandakumar J, Bell CF, Weidenfeld I, Zaug AJ, Leinwand LA, Cech TR. The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity. Nature. 2012;492(7428):285-289.
14. Denchi EL, de Lange T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature. 2007;448(7157):1068-1071.
15. Ramsay AJ, Quesada V, Foronda M, et al. POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia. Nat Genet. 2013;45(5):526-530.
16. Robles-Espinoza CD, Harland M, Ramsay AJ, et al. POT1 lossoffunction variants predispose to familial melanoma. Nat Genet. 2014;46(5):478-481.
17. Shi J, Yang XR, Ballew B, et al. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Nat Genet. 2014;46(5):482-486.
18. Scheurer ME, Etzel CJ, Liu M, et al. Aggregation of cancer in first-degree relatives of patients with glioma. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2007;16(11):2491-2495.
19. Baumann P, Price C. Pot1 and Telomere Maintenance. FEBS Lett. 2010;584(17):3779-3784.